Abviris Deutschland GmbH

The development, manufacture and marketing of innovative in vitro diagnostics and medical devices with the aim of avoiding or alleviating the human papillomavirus (HPV) caused cancer diseases is our mission. Our core competency is in the use of immunological active components, such as a wide range of unique antibodies against different HP viruses and specific antigens. In Germany was the market launch of our first product the Prevo-Check® quick test in the early 2015 This in vitro diagnostic tool and represents the world's first commercially available method for specific screening of HPV-associated oral cavity carcinomas. Abviris Deutschland GmbH was founded in March 2014 by Dr. Ralf Hilfrich. The German market was in Frankfurt/Main the starting point of the company.